CareDx to Report First Quarter 2022 Financial Results

Rhea-AI Summary

CareDx, Inc. (Nasdaq: CDNA) will report its first-quarter 2022 financial results after market close on May 5, 2022. Following the report, company management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can join by calling 877-300-8521 for domestic or 412-317-6026 for international access, using Conference ID: 10165254. CareDx specializes in precision medicine solutions for transplant patients, with offerings that include diagnostic testing and digital healthcare solutions.

Positive

• Upcoming announcement of Q1 2022 financial results, which could provide insights into revenue growth or profitability.
• CareDx's focus on precision medicine for transplant patients positions it well in a specialized healthcare niche.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report financial results for the first quarter 2022 after market close on Thursday, May 5, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 877-300-8521 for domestic callers or 412-317-6026 for international callers. Please reference Conference ID: 10165254. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Investor Relations
Ian Cooney
415-287-2300 x 3550
investor@caredx.com

FAQ

When will CareDx report its Q1 2022 financial results?

CareDx will report its Q1 2022 financial results on May 5, 2022, after market close.

What time is the CareDx conference call for Q1 2022 results?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the CareDx earnings call?

You can listen by calling 877-300-8521 for domestic or 412-317-6026 for international callers, using Conference ID: 10165254. A live webcast is also available on CareDx’s investor relations website.

What is CareDx's focus in the healthcare market?

CareDx is focused on precision medicine solutions specifically for transplant patients, offering diagnostic testing and digital healthcare solutions.